Barriers and challenges of returning patients back to community after renal transplantation in Central Australia

Barriers and challenges of returning patients back to community after renal transplantation in Central Australia

Internal Medicine Journal

  • Author(s): Karepalli, Vijay K., Brown, Megan, Sajiv, Cherian, Fernandes, David, Thomas, Sajan, George, Pratish, Nayar, Sajith, Pawar, Basant
  • Published: 2021
  • Publisher: John Wiley & Sons, Ltd
  • ISBN: 1444-0903

Abstract: Background The majority of patients living in remote communities of Central Australia must relocate to Alice Springs for their dialysis treatments. There is limited information available, about the challenges and barriers that Aboriginal patients encounter in the process of returning back to their communities after renal transplantation. Aim To determine the length of stay of patients in Alice Springs and challenges faced subsequent to renal transplantation, before they could safely return to their remote communities. Methods All transplant recipients from 2012 who are aged 18 were analysed retrospectively. Results Thirty-six patients received renal transplantation from Central Australia. Of them, 25 were from very remote communities of whom 24 were aboriginal. Average length of stay in Alice Springs post transplantation prior to returning to community was 17.2?weeks (121?days). The most common challenge faced prior to returning to community was the need for monitoring and titration of immunosuppressive medication (100%) followed by infections (90%) and admissions to hospital (85%). The other common barrier was optimizing glycaemic control (80%). Less common barriers included proficiency with self-monitoring of blood sugar levels (BSL) (50%), social factors (40%), blood pressure control (25%), safe housing (20%), leukopenia (25%) and rejection episodes (15%). Conclusion Multiple challenges are faced during post-transplantation period in Alice Springs which prolong the time before recipients from remote communities can return home. Some barriers such as titration of immunosuppression are inherent in the transplant journey. However, some factors might be modifiable prior to transplantation. This article is protected by copyright. All rights reserved.

Share this page

Search again